What Conditions Should Be Satisfied Before Releasing Each Tranche of a Milestone-Based Bridge Financing?

Before releasing each tranche of a milestone-based bridge financing, the company must satisfy objective, written conditions and provide evidence the lender can verify. At minimum, the bridge agreement should require achievement of the named milestone, an officer-signed milestone certificate with supporting documentation, confirmation that no default or material adverse change has occurred, and lender or agent approval within a defined review period. Without measurable conditions, clear documentation, and a dispute process, lenders can delay funding and companies can lose access to capital when they need it most.

Milestone-based bridge financing structures the total loan commitment across two or more closings, each tied to a specific company event or performance threshold. The structure exists because lenders extending capital ahead of an equity round carry real uncertainty. The next round may be delayed. The company's position may shift. Releasing the full commitment upfront removes the lender's ability to pause if conditions deteriorate. For founders, the tranche structure is a trade-off: staged capital in exchange for a defined path to each draw. Understanding how to structure a pay-to-play bridge financing when preferred investors decline to participate is the foundation. The tranche conditions are where that structure becomes operational.

The risk of releasing capital without defined conditions runs in both directions. Lenders who fund without clear milestones lose their leverage to pause if the company misses targets. Companies that accept vague milestone language lose clarity on what they must actually deliver to access each draw. Ambiguous conditions invite disputes at exactly the moment the company needs capital. The deal terms that can quietly undermine a raise often come down to language that seemed fine at signing but fails under pressure.

How to Define Milestones That Actually Gate Capital

The most important design decision in a milestone-based bridge is how the milestones are written. A milestone that cannot be objectively verified cannot be enforced.

Use Measurable, Binary Conditions

Milestones should resolve to a yes or no answer. Either the condition is met or it is not. Subjective language creates room for disagreement. Common milestone categories that work well in bridge structures include:

• Revenue thresholds: a specific ARR or MRR figure, measured from audited or accountant-reviewed financials
• Product or regulatory events: FDA clearance, a signed enterprise contract, a completed product launch with a defined deliverable
• Equity process milestones: a signed term sheet from a named or unnamed institutional investor, a board-approved equity raise process launch, or a completed Series A first close
• Cash position: maintaining a minimum cash balance through a defined period, as covered in detail for minimum cash covenant structures in bridge financing

Each milestone should name the measurement date, the measurement method, and who certifies the result.

Avoid Ambiguous Milestone Language

Certain milestone formulations consistently cause problems. Watch for these:

• "Substantial progress toward a Series B" (substantial is undefined)
• "Improved financial performance" (no baseline, no metric)
• "Completion of the product roadmap" (roadmap items can shift)
• "Investor interest from qualified sources" (interest is not a commitment)

The NVCA's October 2025 model document update formally incorporated tranched financing mechanics into standard venture documents for the first time, recommending objective milestones with board certification or third-party validation as the preferred approach. Bridge agreements should follow the same standard.

Set a Milestone Measurement Window

Each milestone needs a measurement date or window. The agreement should specify whether the milestone must be achieved by a hard deadline, within a rolling period, or at any point before the final bridge maturity date. It should also address what happens if the milestone is achieved early: can the company request the tranche ahead of schedule, or does the release follow a fixed calendar regardless of milestone timing?

What Documentation Is Required Before Each Tranche Closes

Milestone achievement alone does not release a tranche. The bridge agreement should require a package of documents to be delivered and approved before funds are wired. This package typically includes:

Some bridge agreements also require a legal opinion confirming the company's authority to borrow and the absence of legal impediments. This is more common in larger bridge rounds or when new lenders are joining at a subsequent tranche closing.

The Lender Review Period

The agreement should define how long the lender has to review the milestone package before the tranche must be funded. A common structure gives the lender five to ten business days to review and either approve or raise a written objection. If no objection is raised within the window, the tranche is deemed approved and the company can demand funding. This protects the company from a lender who delays without cause.

The board's role in reviewing the full tranche package before each close is a related question covered in detail for what information a board should review before approving an insider-led bridge financing.

What Happens When a Milestone Is Disputed or Missed

Disputes over milestone achievement are more common in bridge financing than in standard term loans. The company and the lender may interpret the same metric differently. The bridge agreement should address three scenarios before they arise.

Disputed Milestone Achievement

If a lender disputes whether a milestone has been met, the agreement should provide a resolution mechanism. Options include:

• Escalation to a neutral third party: an independent accountant, auditor, or industry expert who reviews the evidence and issues a binding determination within a defined period
• Board certification as a safe harbor: if the company's board unanimously certifies milestone achievement, the lender's right to dispute is limited to demonstrable factual error
• Cure period before dispute escalates: the company gets a defined window (typically 15 to 30 days) to provide additional evidence before a formal dispute is declared

Without a resolution mechanism, a disputed milestone becomes a litigation question. That outcome is expensive for both sides and almost always avoidable with careful drafting.

Missed Milestones

A missed milestone does not automatically accelerate the bridge. The agreement should specify what happens. Common outcomes include:

• The tranche is postponed until the milestone is achieved, subject to the bridge maturity date
• The parties enter a renegotiation window to adjust the milestone definition or timeline
• The lender gains the right to declare a default if the milestone is missed by more than a defined period

Key point: a missed milestone that triggers default remedies is a serious outcome. Founders should understand the default and remedy provisions before signing. The documentation requirements for investor default remedies in multi-close structures are covered in depth for how to document investor default remedies in a multi-close bridge financing.

Partial Milestone Achievement

The agreement should address what happens if a milestone is substantially but not fully met. A revenue milestone set at $5M ARR with the company at $4.7M is a common scenario. The NVCA's updated model documents suggest building in a partial funding mechanism or renegotiation window for these situations. Founders who negotiate this provision upfront avoid a binary outcome when the company is close but not quite there.

{{main-cta}}

How Defined Tranche Conditions Protected Both Sides During a Delayed Equity Process

A growth-stage software company raised a two-tranche bridge round ahead of a planned Series B. The first tranche funded at closing. The second tranche was conditioned on the company delivering a signed term sheet from a qualified institutional investor within six months.

The equity process moved slower than expected. The company's lead investor prospect requested additional diligence time, pushing the term sheet past the original milestone window. The company had not missed the milestone in substance; the investor was engaged and moving forward. But the six-month window had passed.

Because the bridge agreement included a renegotiation window for milestone timing disputes, the parties were able to extend the measurement period by 90 days without triggering a default. The company provided updated financials, a written confirmation from the prospective investor, and a board resolution authorizing the extension request. The lenders reviewed the package and agreed to the extension within the defined review period.

The second tranche closed eight months after the first. The Series B closed three months after that.

What protected both sides: The milestone was specific (a signed term sheet, not "investor interest"). The agreement had a defined renegotiation window. The company could provide objective evidence of progress. The lenders had a clear review period and a defined approval mechanism. No one had to litigate what "progress" meant because the documents answered the question.

IRC works with companies raising $5M to $250M to structure bridge financing that holds up under pressure, including milestone-based tranches where the equity timeline is uncertain. Getting the conditions right at the term sheet stage is far less costly than resolving a dispute mid-process.

What Founders Should Do Before Signing a Milestone-Based Bridge

Tranche conditions are negotiated at the term sheet stage. Improving them after signing is difficult. Before committing to a milestone-based structure, work through this checklist.

• Map each milestone to a specific, verifiable event. If you cannot describe exactly how you will prove the milestone is met, the language needs work.
• Confirm the measurement method and who certifies it. Board certification, third-party verification, and lender approval are different standards with different implications.
• Negotiate the renegotiation window before you need it. A 30 to 90-day window for milestone timing disputes is standard. Lenders who resist this provision want maximum leverage if timelines slip.
• Understand the default trigger. Know what happens if a milestone is missed by one day, one month, or permanently.
• Review the lender review period. A lender with no defined review deadline can delay a tranche close indefinitely. Require a specific number of business days and a deemed-approval mechanic.

Founders navigating a pay-to-play structure face additional complexity. Milestone timing interacts with any conversion or dilution events tied to the preferred stock. The conditions need to be designed with the full cap table in mind.

IRC Partners structures bridge financings for companies raising $5M to $250M. The time to get the framework right is before the term sheet is signed.

Frequently Asked Questions

Can a lender refuse to fund a tranche even if the company claims the milestone is met?

Yes. Most bridge agreements give the lender the right to review and approve the milestone evidence before funding. If the lender disputes the evidence, the agreement's dispute resolution process applies. This is why the resolution mechanism matters: without one, a lender's refusal to fund can only be challenged through litigation, which is expensive and slow when the company needs capital.

Who typically certifies milestone achievement in a bridge financing?

The CEO or CFO signs a milestone certificate confirming the condition has been met, with supporting evidence attached. Some agreements require board certification as a separate step, particularly for milestones tied to equity process events. Third-party verification by an independent accountant is used when the milestone is a financial metric and the parties want an objective standard that reduces the risk of dispute.

What is a bring-down representation and why is it required at each tranche close?

A bring-down representation is a confirmation that the company's original representations and warranties in the bridge agreement remain true as of the new closing date. It protects lenders from funding into a situation that has materially changed since the prior close, such as undisclosed litigation, a significant customer loss, or a change in the company's financial condition. Founders should review what constitutes a breach before each tranche close.

How does milestone-based tranche timing interact with a pay-to-play conversion event?

If the bridge agreement includes pay-to-play mechanics tied to preferred stock, a tranche close can trigger a conversion or dilution event for non-participating investors. The milestone conditions should be drafted with awareness of when those conversion events occur. A tranche that closes after a pay-to-play deadline may create a different cap table than one that closes before it. Counsel should confirm the sequencing before the bridge is signed.

What happens to unfunded tranches if the company is acquired before all milestones are hit?

This depends on the bridge agreement. Some agreements terminate unfunded tranche commitments upon a change of control. Others require the acquirer to assume the commitment or pay a termination fee. Founders should negotiate the change-of-control treatment of unfunded tranches at the term sheet stage, particularly if an acquisition is a realistic near-term outcome.

Can milestone conditions be waived, and who has the authority to waive them?

Yes, milestone conditions can be waived if the required consent is obtained. Most bridge agreements require the consent of lenders holding a majority of the outstanding principal, or in some cases unanimous consent, to waive a condition. Founders should confirm the waiver threshold before signing. A waiver threshold that requires unanimous consent gives any single lender veto power over a tranche release, which can create leverage problems if the lender group is not aligned.

Is a use-of-proceeds restriction on each tranche enforceable, and what happens if the company violates it?

Use-of-proceeds restrictions are enforceable if they are clearly defined in the bridge agreement. A violation typically constitutes an event of default, which can trigger acceleration of the outstanding principal and accrued interest. In practice, lenders rarely accelerate for a minor use-of-proceeds deviation, but the legal right exists. Founders should negotiate use-of-proceeds language that is specific enough to satisfy lenders but broad enough to allow operational flexibility as conditions change.

Continue reading this series:

• What happens to non-participating preferred stockholders in a pay-to-play bridge round
• How should founders negotiate a bridge financing round when an existing investor requests enhanced pro-rata rights
• How should a startup structure bridge financing if a major customer contract is expected to be the next financing catalyst

IRC Partners advises operators raising $5M to $250M of institutional capital on structure, positioning, and round architecture. We take seven strategic partners per quarter. No placement agent model. No success-only theater. Capital is raised on the strength of how the deal is built. If you want your current raise reviewed before it reaches the market and silently fails, apply here.